Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Development

Patient Outcomes

CBD–THC Pair Shows Synergistic Killing of Ovarian Cancer Cells in Lab Study

Researchers urge animal studies with pharmacokinetic testing before any clinical use.

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market